Bill · S. 4941· Senate(119-S-4941)
Modernizing Opioid Treatment Access Act 2.0 of 2026
- Introduced
- 6/24/2026
- Last activity
- 6/24/2026 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sponsored by
- Edward Markey
- Cosponsors
- - 6 - 1
- Introduced
- In Committee
What this bill would do
The Modernizing Opioid Treatment Access Act 2.0 of 2026 aims to expand access to methadone for treating opioid use disorder. It allows certain qualified practitioners to prescribe methadone to be dispensed through pharmacies for supervised or unsupervised use. These practitioners include specific addiction medicine specialists or those determined qualified by the Secretary. The bill mandates that prescribing occurs exclusively via electronic means for liquid or dispersible tablet formulations. Additionally, treatment may be provided through telemedicine. The Act also establishes oversight through required reports to Congress from the DEA.
Yes· 3 of 4
Does this do more about addiction and overdose deaths?+8
The bill directly targets the opioid crisis by diversifying treatment access methods.
Does this make health care easier to get in general?+7
The bill expands access to methadone treatment through pharmacies and telemedicine.
Does this make what the government does easier for the public to see?+5
The bill mandates annual reports to Congress regarding methadone prescribing and registration statistics.
The opposite
Does this protect people from being watched or searched?-2
The bill notes potential differences in confidentiality protections when using pharmacies for dispensing.
Who it would affect, and how
Potential Positive Impacts for People
-
Expanded Access to Treatment: The bill allows methadone to be dispensed through a pharmacy for an individual's own supervised or unsupervised use, which expands how people can receive care (Section 2, paragraph (2)(A)).
-
Use of Telemedicine: Maintenance treatment or detoxification treatment can be provided through the practice of telemedicine (Section 2, paragraph (2)(G)).
-
Streamlined Pharmacy Dispensing: Pharmacies are not required to obtain a separate registration to dispense methadone to an individual prescribed the medication by a registered practitioner (Section 2, paragraph (2)(H)).
Potential Negative Impacts for People
-
Confidentiality Risks: Individuals must be informed of specific differences in confidentiality protections when dispensing through a pharmacy instead of through an opioid treatment program (Section 2, paragraph (2)(E)(ii)).
-
State-Level Restrictions: A State has the power to request that the Attorney General cease registering, revoke existing registrations, or deny pending applications for these specific practitioners within that State (Section 2, paragraph (2)(F)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Opioid Crisis Response+8Improves Healthcare Access+7
- Governance And Ideology
- Improves Government Transparency+5Increase States Rights+3Improves Privacy Rights-2
- 9/15/2026
- 1 Cosponsor added.
- 7/13/2026
- 2 Cosponsors added.
- 6/24/2026
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 5 Cosponsors added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Cory BookerDemocrat · New Jersey
Tammy DuckworthDemocrat · Illinois
Maggie HassanDemocrat · New Hampshire
Jeff MerkleyDemocrat · Oregon
Rand PaulRepublican · Kentucky
Bernie SandersIndependent · Vermont
Tina SmithDemocrat · Minnesota
Elizabeth WarrenDemocrat · Massachusetts